Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX)

272 filings reported holding PTGX - Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 as of Q3 2024.
Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 61,602,509 shares of 62,162,717 outstanding shares and own 99.1% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (10,224,295 shares), FARALLON CAPITAL MANAGEMENT LLC (5,861,006 shares), RTW INVESTMENTS, LP (5,426,112 shares), VANGUARD GROUP INC (4,216,081 shares), STATE STREET CORP (3,183,542 shares), JOHNSON & JOHNSON (2,449,183 shares), BVF INC/IL (1,850,167 shares), Jefferies Financial Group Inc. (1,814,696 shares), Pacer Advisors, Inc. (1,734,090 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,374,697 shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.